Daily Judi: Thursday, March 2, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Eli Lilly announced it will cap out-of-pocket monthly expense of its insulin at $35. (NBC News)
Rachael Levy and Marisa Taylor report on Neuralink's moves toward human trials for its brain implant, intended to treat conditions such as paralysis. The company, founded in 2016 by Elon Musk, has yet to receive FDA approval. (Reuters)
Fast Company lists its 10 most innovative medical device companies for 2023.
Our Culture
“We are small enough that we are nimble, so we can prioritize quickly, yet also of significant size that we allocate resources where needed. We truly do a lot. This is my dream job. Judi allows me to have a bigger impact. And we do great work.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.